REGENXBIO Inc. (RGNX) Cash Flow Statement
REGENXBIO Inc. (RGNX) generated -$246.7M of operating cash flow over the twelve months to 2026-06-30, spent $3.0M on capital expenditure and had free cash flow of -$249.7M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RGNXREGENXBIO Inc.Follow RGNX — free
—
Price chart with a free account
- Market cap
- 441.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.02 | -0.05 | -0.06 | 0.10 | -0.11 | -0.05 | 0.22 | -0.21 | -0.17 | -0.12 | -0.25 | |
| Capital expenditure | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.08 | 0.03 | 0.00 | 0.00 | -0.00 | |
| Free cash flow | -0.02 | -0.06 | -0.07 | 0.09 | -0.12 | -0.08 | 0.13 | -0.24 | -0.18 | -0.13 | -0.25 | |
| Stock-based compensation | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | — |
USD billions · SEC XBRL
REGENXBIO Inc. — questions
- What is REGENXBIO Inc.'s operating cash flow?
- -$246.7M over the twelve months to 2026-06-30.
- How much does REGENXBIO Inc. spend on capital expenditure?
- $3.0M over the twelve months to 2026-06-30.
- What is REGENXBIO Inc.'s free cash flow?
- -$249.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from REGENXBIO Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.